| 000 | 00881 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516145705.0 | ||
| 264 | 0 | _c20140521 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2013.04.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFisman, David N | |
| 245 | 0 | 0 |
_aResponse to O'Brien et al. _h[electronic resource] |
| 260 |
_bVaccine _cAug 2013 |
||
| 300 |
_a3638-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRotavirus Infections _xepidemiology |
| 650 | 0 | 4 |
_aRotavirus Vaccines _xeconomics |
| 650 | 0 | 4 |
_aVaccination _xeconomics |
| 700 | 1 | _aLee, Victoria | |
| 700 | 1 | _aNaus, Monika | |
| 773 | 0 |
_tVaccine _gvol. 31 _gno. 36 _gp. 3638-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2013.04.020 _zAvailable from publisher's website |
| 999 |
_c22709544 _d22709544 |
||